Menu
Back to User profile » Dr Huijuan Cheng
Papers published by Dr Huijuan Cheng:
Retraction
IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Retraction]
Li Y, Chen G, Han Z, Cheng H, Qiao L, Li Y
OncoTargets and Therapy 2022, 15:871-872
Published Date: 22 August 2022
Corrigendum
IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Corrigendum]
Li Y, Chen G, Han Z, Cheng H, Qiao L, Li Y
OncoTargets and Therapy 2020, 13:12253-12254
Published Date: 27 November 2020
Original Research
Retracted Article: IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells
Li Y, Chen G, Han Z, Cheng H, Qiao L, Li Y
OncoTargets and Therapy 2020, 13:9721-9730
Published Date: 30 September 2020